1. The changes in the blood glucose concentration over time after treatment of insulin and glucose
To maximize insulin dose, all mice in this study were supplied with 10% glucose drinking water. Insulin was injected subcutaneously twice at an interval time of 12 h. Both 0.1 U and 0.15 U per mouse led to hypoglycemia defined as a blood glucose concentration below 4 mmol/L (Fig. 1). The doses of 0.025 and 0.05 units per mouse did not cause hypoglycemia (Fig. 1). To induce insulin action in the kidneys, an insulin dose of 0.05 units per mouse was chosen to determine whether insulin pretreatment could protect the kidney from IRI.
2. Pretreatments Of Insulin And Glucose For 24 H Protected The Kidney From IRI
The mice subjected to kidney IRI demonstrated renal dysfunction, which manifested by significant increases in BUN and serum creatinine concentration (Figs. 2A and B). Insulin pretreatment preserved the renal function from IRI. The pathological examination revealed that the renal damage in IRI was characterized by tubular dilation, sloughing of tubular epithelial cells, cast formation, and loss of the brush border in the tubular epithelial cells (Fig. 2C). The tubular damage score was used to evaluate the renal damage. Insulin pretreatment protected the kidney from pathological IRI damage through the decrease in the tubular damage score (Fig. 2D). The results suggested that insulin pretreatment protected the kidney from IRI through the preservation of renal function and morphology.
3. The pretreatment-induced protection was associated with the activation of AKT, reduction of BAX, and caspase-3 expression
Immunofluorescence analysis revealed that insulin activation AKT by phosphate AKT (P-AKT) around the nuclei of tubular epithelial cells (Fig. 3A). P-AKT would transfer from the cytoplasm to the nucleus after renal IRI. Bax—a component molecule in apoptotic signaling—was highly expressed in the nucleus of tubular epithelial cells after IRI in the kidney (Fig. 3B). Caspase-3, a critical executioner of apoptosis, exhibited in the nucleus of tubular epithelial cells in the kidney after IRI (Fig. 3C). Statistical analysis indicated that insulin-induced AKT activation could attenuate the expression of Bax and caspase-3 in the kidney after IRI (Figs. 3D-F).
Western blot analysis revealed that insulin could activate AKT by P-AKT in the kidney (Fig. 4A). The activation of AKT decreased the expression of Bax and caspase-3 after IRI in the kidney (Figs. 4A, C, and D). The western blot results were consistent with the immunofluorescence results. The results suggested that insulin pretreatment may protect the kidney from IRI through the inhibition of the apoptotic signaling pathway.
4. Pretreatments with insulin and glucose decreased IRI-induced tubular apoptosis.
To further confirm the anti-apoptosis effect of insulin, a Tunnel assay was used to detect the apoptosis in the IRI kidney (Fig. 5A). Insulin pretreatment partially reversed the renal apoptosis that was caused by IRI (Fig. 5B).
5. The Protection Of Insulin And Glucose Was Partially Reversed By An AKT Inhibitor
Based on the aforementioned results, insulin pretreatment would protect the kidney from IRI through the activation of AKT, which subsequently attenuates renal apoptosis. To further confirm the critical role of AKT in insulin-induced renal protection, an AKT inhibitor was used to assess the effect of insulin on the IRI kidney. An AKT inhibitor exacerbated renal function and damaged the IRI kidney in the presence of insulin (Figs. 6A-D). The number of apoptotic cells still worsened when an AKT inhibitor was used with insulin (Figs. 7A-B). Western blot analysis revealed that an AKT inhibitor blocked insulin-induced AKT activation (Figs. 8A-D). In the presence of insulin, an AKT inhibitor also significantly increased Bax/caspase expression and exacerbated renal apoptosis in IRI kidneys. The results suggested that insulin-induced renal protection depends on AKT activation and subsequent attenuation of apoptosis.
6. Extension of pretreatment duration failed to improve continuously the protective effect in the IRI kidney
Since insulin pretreatment protects the kidney from IRI, an extension of the pretreatment time may time-dependently improve renal protection. To confirm the effect of pretreatment time, we compared the renal protective effects of insulin pretreatment for 1, 3, and 6 days. However, there were no differences in Cre concentration, BUN concentration, and tubular damage score between 1-, 3-, and 6-day insulin pretreatments (Figs. 9A-D). There was no difference in P-AKT/Bax/caspase-3 expression between 1-, 3-, and 6-day insulin pretreatments (Figs. 10A-D). The results indicated that a short-term insulin pretreatment (24 h) is sufficient to induce renal protection from IRI.